Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis)

被引:17
|
作者
Mitchell, Adam [1 ]
Misialek, Jeffrey R. [2 ]
Folsom, Aaron R. [2 ]
Duprez, Daniel [1 ]
Alonso, Alvaro [2 ]
Jerosch-Herold, Michael [3 ]
Sanchez, Otto A. [2 ]
Watson, Karol E. [4 ]
Sallam, Tamer [4 ]
Konety, Suma H. [1 ]
机构
[1] Univ Minnesota, Dept Med, Sch Publ Hlth, Div Cardiol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[3] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[4] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA
关键词
ISCHEMIA SYNDROME EVALUATION; CORONARY FLOW; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; BNP EXPRESSION; HEART-FAILURE; RISK-FACTORS; RESERVE; DISEASE; POPULATION;
D O I
10.1016/j.amjcard.2015.02.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study sought to investigate the relation between myocardial perfusion and N-terminal probrain natriuretic peptide (NT-proBNP) in asymptomatic adults without overt coronary artery disease. NT-proBNP is a cardiac neurohormone secreted from the ventricles in response to ventricular volume expansion and pressure overload and may also be elevated in the setting of reduced myocardial perfusion. We hypothesized that reduced myocardial perfusion reserve (VIPR) would be associated with elevated NT-proBNP in participants free of overt cardiovascular disease. MPR was measured by cardiac magnetic resonance, before and after adenosine infusion, in 184 MESA participants (mean age 60 +/- 10.4,58% white, 42% Hispanic, 44% women) without overt cardiovascular disease. MPR was modeled as hyperemic myocardial blood flow (MBF) adjusted for MBF at rest. A linear regression analysis, adjusted for demographics, established cardiovascular risk factors, left ventricular mass, coronary calcium score, body mass index, and medications, was used to determine the association between MPR and NT-proBNP. Participants with low hyperemic MBF were more likely to be older, male, diabetic, and have higher blood pressure and higher coronary artery calcium score. Mean hyperemic MBF was 3.04 0.829 ml/min/g. MPR was inversely associated with NT-proBNP levels. In a fully adjusted model, every 1-SD decrement in MPR was associated with a 21% increment in NT-proBNP (p = 0.04). In conclusion, MPR is inversely associated with NT-proBNP level in this cross-sectional study of asymptomatic adults free of overt coronary artery disease, suggesting that higher NT-proBNP levels may reflect subclinical myocardial microvascular dysfunction. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1341 / 1345
页数:5
相关论文
共 50 条
  • [11] N-terminal pro-brain natriuretic peptide levels and aortic diameters
    Gutin, Liat S.
    Bakalov, Vladimir K.
    Rosing, Douglas R.
    Arai, Andrew E.
    Gharib, Ahmed M.
    Bondy, Carolyn A.
    AMERICAN HEART JOURNAL, 2012, 164 (03) : 419 - 424
  • [12] The biomarker N-terminal pro-brain natriuretic peptide and liver diseases
    Wang, Ling
    Geng, Jiabao
    Li, Jie
    Li, Tong
    Matsumori, Akira
    Chang, Yibin
    Lu, Fengmin
    Zhuang, Hui
    CLINICAL AND INVESTIGATIVE MEDICINE, 2011, 34 (01): : E30 - E37
  • [13] N-terminal pro-brain natriuretic peptide and abnormal brain aging The AGES-Reykjavik Study
    Sabayan, Behnam
    van Buchem, Mark A.
    de Craen, Anton J. M.
    Sigurdsson, Sigurdur
    Zhang, Qian
    Harris, Tamara B.
    Gudnason, Vilmundur
    Arai, Andrew E.
    Launer, Lenore J.
    NEUROLOGY, 2015, 85 (09) : 813 - 820
  • [14] Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea
    Alibay, Y
    Beauchet, A
    El Mahmoud, R
    Schmitt, C
    Brun-Ney, D
    Benoit, MO
    Dubourg, O
    Boileau, C
    Jondeau, G
    Puy, H
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (1-2) : 20 - 24
  • [15] N-terminal pro-brain natriuretic peptide in newly diagnosed acromegaly
    Arikan, S.
    Bahceci, M.
    Tuzcu, A.
    Gokalp, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (08) : 571 - 575
  • [16] N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study
    Bower, Julie K.
    Lazo, Mariana
    Matsushita, Kunihiro
    Rubin, Jonathan
    Hoogeveen, Ron C.
    Ballantyne, Christie M.
    Selvin, Elizabeth
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (10) : 1262 - 1266
  • [17] Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis
    Sanchez, Otto A.
    Lazo-Elizondo, Mariana
    Zeb, Irfan
    Tracy, Russell P.
    Bradley, Ryan
    Duprez, Daniel A.
    Bahrami, Hossein
    Peralta, Carmen A.
    Daniels, Lori B.
    Lima, Joao A.
    Maisel, Alan
    Jacobs, David R., Jr.
    Budoff, Mathew J.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (05): : 728 - 735
  • [18] Preoperative N-terminal pro-brain natriuretic peptide is associated with Fontan outcomes
    Lin, Hsin-Chia
    Huang, Shu-Chien
    Wu, Mei-Hwan
    Wang, Jou-Kou
    Lin, Ming-Tai
    Chen, Chun-An
    Lu, Chun-Wei
    Chen, Yih-Sharng
    Chiu, Shuenn-Nan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03) : 770 - +
  • [19] N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease
    Vilar-Bergua, Andrea
    Riba-Llena, Iolanda
    Penalba, Anna
    Maria Cruz, Luz
    Jimenez-Balado, Joan
    Montaner, Joan
    Delgado, Pilar
    NEUROLOGY, 2016, 87 (24) : 2533 - 2539
  • [20] N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community The Hisayama Study
    Doi, Yasufumi
    Ninomiya, Toshiharu
    Hata, Jun
    Hirakawa, Yoichiro
    Mukai, Naoko
    Ikeda, Fumie
    Fukuhara, Masayo
    Iwase, Masanori
    Kiyohara, Yutaka
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (12) : 2997 - 3003